All years

June 2017 - Dr. Paolo Cesare, Head of Neuro Microphysiological Systems Group at NMI, participates to a newly launched IMI project: Modelling neuron-glia networks into a drug discovery platform for efficacious pain treatments (NGN-PET)

The new research project NGN-PET was launched in the framework of the Innovative Medicine Initiative (IMI), the largest public-private partnership (PPP) for health research worldwide co-funded by the EU and the European pharmaceutical industry.


22.06.2017 - NMI TT Pharmaservices and Charité awarded grant for development of multiplex protein profiling for individualization of tumor therapy

Berlin/Germany, June 22, 2017 – Contract research provider NMI TT Pharmaservices and Charité Universitätsmedizin Berlin today announced that they have been awarded a research grant for development of a multiplex protein profiling based platform that


18th International EAU17 Meeting - London

Poster prize in Oncologie for our research group tumor biology


25.11.2016 - Pluriomics User Meeting

The NMI is sending their expert on MEA technologies to Leiden: Udo Kraushaar has wide experience in this field and will point out the advantages as well as the challenges of the MEA technologies.

Displaying results ###SPAN_BEGIN###%s to %s out of ###SPAN_BEGIN###%s
<< First < Previous 1-5 6-10 11-15 16-20 21-25 26-30 31-35 Next > Last >>